109 related articles for article (PubMed ID: 3492810)
1. A human T-cell line resistant to cytopathic effects of the human immunodeficiency virus (HIV).
Casareale D; Stevenson M; Sakai K; Volsky DJ
Virology; 1987 Jan; 156(1):40-9. PubMed ID: 3492810
[TBL] [Abstract][Full Text] [Related]
2. Analysis of long-term viral expression in CEM cells persistently infected with non syncytium-inducing HIV-1 strains.
Yelle J; Morisset R; Thibodeau L
Arch Virol; 1994; 139(1-2):155-72. PubMed ID: 7826207
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus enhances lysis of HIV-infected T lymphoblasts.
Casareale D; Fiala M; Chang CM; Cone LA; Mocarski ES
Int J Cancer; 1989 Jul; 44(1):124-30. PubMed ID: 2545634
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of cell surface molecules during noncytopathic infection of T cells with human immunodeficiency virus.
Stevenson M; Zhang XH; Volsky DJ
J Virol; 1987 Dec; 61(12):3741-8. PubMed ID: 3500327
[TBL] [Abstract][Full Text] [Related]
5. New CD4(+) cell line susceptible to infection by HIV-1.
Tremblay M; Sullivan AK; Rooke R; Geleziunas R; Tsoukas C; Shematek G; Gilmore N; Wainberg MA
J Med Virol; 1989 Aug; 28(4):243-9. PubMed ID: 2570823
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of human monoclonal antibody-producing B cell lines to infection by human immunodeficiency virus.
Shepherd AJ; Boyd JE; Hogg CL; Aw D; James K
Hum Antibodies Hybridomas; 1992 Oct; 3(4):168-76. PubMed ID: 1335786
[TBL] [Abstract][Full Text] [Related]
7. Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I.
De Rossi A; Franchini G; Aldovini A; Del Mistro A; Chieco-Bianchi L; Gallo RC; Wong-Staal F
Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4297-301. PubMed ID: 2424024
[TBL] [Abstract][Full Text] [Related]
8. Human T-lymphoblastoid cells selected for growth in serum-free medium provide new tools for study of HIV replication and cytopathogenicity.
Yahi N; Fantini J; Baghdiguian S; Chermann JC
J Virol Methods; 1991; 34(2):193-207. PubMed ID: 1725173
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility to infection by the human immunodeficiency virus (HIV) correlates with T4 expression in a parental monocytoid cell line and its subclones.
Asjö B; Ivhed I; Gidlund M; Fuerstenberg S; Fenyö EM; Nilsson K; Wigzell H
Virology; 1987 Apr; 157(2):359-65. PubMed ID: 3103330
[TBL] [Abstract][Full Text] [Related]
10. Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone.
Franchini G; Fargnoli KA; Giombini F; Jagodzinski L; De Rossi A; Bosch M; Biberfeld G; Fenyo EM; Albert J; Gallo RC
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2433-7. PubMed ID: 2648404
[TBL] [Abstract][Full Text] [Related]
11. HTLV-III infection of EBV-genome-positive B-lymphoid cells with or without detectable T4 antigens.
Salahuddin SZ; Ablashi DV; Hunter EA; Gonda MA; Sturzenegger S; Markham PD; Gallo RC
Int J Cancer; 1987 Feb; 39(2):198-202. PubMed ID: 3026971
[TBL] [Abstract][Full Text] [Related]
12. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses.
Kishi M; Nishino Y; Sumiya M; Ohki K; Kimura T; Goto T; Nakai M; Kakinuma M; Ikuta K
J Gen Virol; 1992 Jan; 73 ( Pt 1)():77-87. PubMed ID: 1730943
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines.
Chaffee S; Leeds JM; Matthews TJ; Weinhold KJ; Skinner M; Bolognesi DP; Hershfield MS
J Exp Med; 1988 Aug; 168(2):605-21. PubMed ID: 3261775
[TBL] [Abstract][Full Text] [Related]
14. Low-cytopathic infectious clone of human immunodeficiency virus type I (HIV-I).
Sakai K; Ma XY; Volsky DJ
FEBS Lett; 1988 Oct; 238(2):257-61. PubMed ID: 2458968
[TBL] [Abstract][Full Text] [Related]
15. Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent human immunodeficiency virus type 1 infection of CEM cells.
Pauza CD; Galindo JE; Richman DD
J Exp Med; 1990 Oct; 172(4):1035-42. PubMed ID: 2212939
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia.
Han T; Ozer H; Minowada J
Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of human glial cells to infection with human immunodeficiency virus (HIV).
Dewhurst S; Bresser J; Stevenson M; Sakai K; Evinger-Hodges MJ; Volsky DJ
FEBS Lett; 1987 Mar; 213(1):138-43. PubMed ID: 3549356
[TBL] [Abstract][Full Text] [Related]
18. Thymosin beta 4 induced phenotypic changes in Molt-4 leukemic cell line.
Kokkinopoulos D; Perez S; Papamichail M
Blut; 1985 Jun; 50(6):341-8. PubMed ID: 2988673
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus.
Folks T; Benn S; Rabson A; Theodore T; Hoggan MD; Martin M; Lightfoote M; Sell K
Proc Natl Acad Sci U S A; 1985 Jul; 82(13):4539-43. PubMed ID: 2989831
[TBL] [Abstract][Full Text] [Related]
20. Syncytium formation and destruction of bystander CD4+ cells cocultured with T cells persistently infected with human immunodeficiency virus as demonstrated by flow cytometry.
Schols D; Pauwels R; Baba M; Desmyter J; De Clercq E
J Gen Virol; 1989 Sep; 70 ( Pt 9)():2397-408. PubMed ID: 2789268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
